NCIt definition : An orally bioavailable inhibitor of CXC Chemokine Receptor 4 (CXCR4) with potential
antineoplastic activity. CXCR4 antagonist BL-8040 selectively binds to the chemokine
receptor CXCR4, preventing the binding of stromal derived factor 1 (SDF-1 or CXCL12)
to the CXCR4 receptor and subsequent receptor activation, which may result in decreased
tumor cell proliferation and migration. In addition, inhibition of CXCR4 may induce
mobilization of hematopoietic cells from the bone marrow into blood. The G protein-coupled
receptor CXCR4 plays an important role in chemotaxis and angiogenesis and is upregulated
in several tumor cell types; SDF-1/CXCR4 interaction induces retention of hematopoietic
cells in the bone marrow.;
UNII : DA9G065962;
InChIKey : JJVZSYKFCOBILL-MKMRYRNGSA-N;
CAS number : 664334-36-5;
Molecule name : TF-14016; BL-8040; BKT 140; BL 8040; BKT-140;